JANET SYBIL BIERMANN, MD

ANN ARBOR, MI

Research Active
Orthopaedic Surgery NPI registered 20+ years 50 publications 2007 – 2025 NPI: 1245330075

Practice Location

1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109-5000

Phone: (734) 936-4000

What does JANET BIERMANN research?

Dr. Biermann studies different forms of bone and soft tissue cancers, including Ewing sarcoma, osteosarcoma, and soft tissue sarcomas. Her research aims to analyze treatment methods like chemotherapy, radiation, and surgery, helping to improve survival rates for young cancer patients. Additionally, she looks at the nuances of surgical approaches, such as unplanned surgeries related to tumor size and grade, and works on enhancing guidelines for medical professionals to ensure better patient outcomes. Her experience also extends to improving maternity leave and support for female medical residents.

Key findings

  • In bone cancer treatment, combining chemotherapy and targeted therapies has led to higher cure rates for Ewing sarcoma and osteosarcoma patients.
  • For patients with soft tissue sarcoma, those with tumors smaller than 5 cm had unplanned surgeries in 41.6% of cases, compared to only 18.8% for larger tumors, highlighting the need for thorough evaluations.
  • Patients with radiation-associated osteosarcoma had a median overall survival of 12.2 months, substantially lower than the 27.6 months for sporadic osteosarcoma patients, indicating a need for tailored treatment strategies.

Frequently asked questions

Does Dr. Biermann study bone cancer?
Yes, Dr. Biermann conducts extensive research on bone cancers, including Ewing sarcoma and osteosarcoma, focusing on improving treatment methods and guidelines.
What factors affect surgical outcomes in soft tissue sarcomas?
Dr. Biermann's research indicates that the size and grade of soft tissue sarcomas significantly influence surgical outcomes, with larger tumors having higher rates of complications.
What are the latest findings on multiple myeloma treatment?
Dr. Biermann reviews updated guidelines for treating multiple myeloma, highlighting new treatment options aimed at enhancing patient care and outcomes.
How does Dr. Biermann’s work impact female medical residents?
Her research addresses the challenges faced by female medical residents, particularly regarding maternity leave and the impact on their wellness and career decisions.
What are bone-modifying agents and their relevance?
Bone-modifying agents are treatments for patients with cancers like breast cancer that have spread to the bones. Dr. Biermann found these agents help manage pain, but should be combined with other strategies for best results.

Publications in plain English

Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

2025

Journal of the National Comprehensive Cancer Network : JNCCN

Biermann JS, Hirbe A, Ahlawat S, Bernthal NM, Binitie O +34 more

Plain English
This paper studied two common types of bone cancer called Ewing sarcoma and osteosarcoma, which make up 36% of primary bone cancers, especially in children and teenagers. Researchers found that better treatment strategies, including a mix of chemotherapy, targeted therapies, surgery, and radiation, are leading to higher cure rates and longer survival for patients with these cancers. This is important because it means that more young patients are beating these tough diseases. Who this helps: Patients and their families dealing with Ewing sarcoma and osteosarcoma.

PubMed

Analysis of the Effect of the Size and Grade of Soft Tissue Sarcoma on Rates of Unplanned Resection, Metastatic Disease, Mortality, and Morbid Re-Resection Over 20 Years.

2021

Orthopedics

Gagnet P, Nelson J, Wallace N, McCarthy C, Robbins C +3 more

Plain English
This study looked at patients with soft tissue sarcomas, which are rare tumors, to see how size and grade affect surgical outcomes. Among 836 patients analyzed, those with tumors smaller than 5 cm had unplanned surgeries in 41.6% of cases, while those with larger tumors had unplanned surgeries in only 18.8%. Larger tumors also had much higher rates of spreading to other parts of the body: 50.7% for larger tumors compared to 19.7% for smaller ones. These findings highlight the importance of proper evaluation before surgery, especially for smaller tumors that are often treated without thorough checks. Who this helps: This helps patients with soft tissue sarcomas by ensuring they receive more careful surgical planning and evaluation.

PubMed

Childbearing Decisions in Residency: A Multicenter Survey of Female Residents.

2020

Academic medicine : journal of the Association of American Medical Colleges

Stack SW, Jagsi R, Biermann JS, Lundberg GP, Law KL +5 more

Plain English
This study looked at how female medical residents decide when to have children and what factors influence these decisions. Out of 804 respondents, 61% of those who were married or partnered reported they were delaying childbearing, mainly due to busy work schedules (93%) and the desire not to prolong their residency (53%). Only 38% were satisfied with their choice to delay, indicating a need for better support for these residents. Who this helps: This research benefits female medical residents and those involved in medical training programs.

PubMed

Maternity Leave in Residency: A Multicenter Study of Determinants and Wellness Outcomes.

2019

Academic medicine : journal of the Association of American Medical Colleges

Stack SW, Jagsi R, Biermann JS, Lundberg GP, Law KL +5 more

Plain English
This study looked at maternity leave for female doctors in training (residents) and how the length of their leave affects their well-being after having a baby. Out of over 1,500 surveyed residents, 16% were mothers, most of whom took about 6 weeks off, often using vacation or sick leave. The findings show that longer leaves lead to better breastfeeding rates and less burnout, highlighting the need for clearer policies and better support for new mothers during residency. Who this helps: This benefits female medical residents and their families.

PubMed

Differential Outcomes and Biologic Markers of Radiation-Associated vs. Sporadic Osteosarcoma: A Single-Institution Experience.

2019

Frontiers in oncology

Siontis BL, McHugh JB, Roberts E, Zhao L, Thomas DG +5 more

Plain English
This study compared two types of osteosarcoma: radiation-associated osteosarcoma (RAO), which can develop after radiation treatment, and sporadic osteosarcoma (SO), which occurs without prior radiation. Researchers examined data from 159 patients, finding that those with RAO had worse outcomes when the disease was localized, with a median overall survival of 12.2 months compared to 27.6 months for patients with SO. The study highlighted that RAO patients might have different biological markers, like higher levels of certain proteins, which could explain these poorer outcomes. Who this helps: This research benefits patients with osteosarcoma, especially those who have had previous radiation treatments.

PubMed

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

2018

Journal of the National Comprehensive Cancer Network : JNCCN

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS +25 more

Plain English
This paper reviews updated guidelines for diagnosing and treating multiple myeloma, a type of blood cancer. Key changes include new treatment options and care recommendations to improve patient outcomes, helping ensure that patients receive the most effective therapies available. These updates aim to enhance overall care and support during treatment. Who this helps: This helps patients with multiple myeloma and their healthcare providers.

PubMed

Surgical Approach to Bone Metastases.

2018

Current osteoporosis reports

Siegel GW, Biermann JS, Calinescu AA, Spratt DE, Szerlip NJ

Plain English
This study looked at how the surgical treatment of bone metastases, cancer that has spread to the bones, has changed with new therapies. It found that advancements in targeted chemotherapy and focused high-dose radiation have led to less invasive surgeries, allowing for quicker recovery and less pain for patients. This shift emphasizes the need for personalized treatment plans based on each patient's specific goals. Who this helps: Patients with bone metastases benefit from these improved surgical techniques and treatment options.

PubMed

NCCN Guidelines Insights: Bone Cancer, Version 2.2017.

2017

Journal of the National Comprehensive Cancer Network : JNCCN

Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR +26 more

Plain English
This research looks at the best ways to treat different types of bone cancer, specifically focusing on Ewing sarcoma. The experts created guidelines based on the latest research to help doctors choose the best treatments for their patients. These guidelines are important because they can improve patient outcomes and ensure more consistent care across healthcare providers. Who this helps: This helps patients with bone cancer and the doctors treating them.

PubMed

Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

2017

Journal of the National Comprehensive Cancer Network : JNCCN

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS +24 more

Plain English
This paper discusses the latest guidelines for treating multiple myeloma (MM), a type of cancer that affects plasma cells in the bone marrow and can lead to various health issues like bone damage, kidney problems, and anemia. The guidelines outline best practices for managing different forms of plasma cell disorders, especially for patients who have just been diagnosed with MM. These recommendations are important as they help ensure patients receive the most effective treatment options available. Who this helps: These guidelines benefit patients diagnosed with multiple myeloma and their healthcare providers.

PubMed

Root Cause Analysis and Actions for the Prevention of Medical Errors: Quality Improvement and Resident Education.

2017

Orthopedics

Charles R, Hood B, DeRosier JM, Gosbee JW, Bagian JP +4 more

Plain English
This research focused on improving the quality of care in orthopedic surgery by examining a method called root cause analysis and actions (RCA2), which helps identify and prevent medical mistakes. The study found that involving trainees, or residents, in this process not only taught them about patient safety but also led to significant improvements in surgical care. For example, schools implementing RCA2 reported fewer surgical errors thanks to this hands-on approach to quality improvement. Who this helps: This benefits patients undergoing orthopedic surgery and their surgeons.

PubMed

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.

2017

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Van Poznak C, Somerfield MR, Barlow WE, Biermann JS, Bosserman LD +11 more

Plain English
This study reviewed the use of bone-modifying agents (BMAs) for patients with breast cancer that has spread to the bones. The researchers found that treatments like denosumab and zoledronic acid can help manage bone pain and are recommended for these patients, but the pain relief they provide is limited. It’s important to combine BMAs with other pain management strategies, rather than relying on them alone. Who this helps: This helps patients with metastatic breast cancer and their healthcare providers.

PubMed

Core Concepts: Orthopedic Intern Curriculum Boot Camp.

2016

Orthopedics

Seeley MA, Kazarian E, King B, Biermann JS, Carpenter JE +2 more

Plain English
This study looked at how an intensive training program, called a boot camp, can help new orthopedic surgical interns quickly learn essential clinical skills. Researchers found that after completing this 3-month program, the first-year residents significantly improved their skills in areas like sterile technique and wound closure, matching the abilities of second-year residents. This matters because it shows that early and focused training can help interns become more competent faster, benefiting patient care. Who this helps: This helps orthopedic surgical interns and their future patients.

PubMed

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

2016

Journal of the National Comprehensive Cancer Network : JNCCN

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC +24 more

Plain English
This study looked at the latest updates in the guidelines for treating multiple myeloma, a type of blood cancer. It highlighted new recommendations for how to diagnose and manage the disease, as well as new treatment options that are now available. These updates are important because they can help doctors provide better care for patients, improving their chances of successful treatment. Who this helps: Patients with multiple myeloma.

PubMed

Staged Soft Tissue Reconstruction Following Sarcoma Excision with Anticipated Large Cutaneous Defects: An Oncologically Safe Alternative.

2016

The Iowa orthopaedic journal

Siegel GW, Kuzon WM, Hasen JM, Biermann JS

Plain English
In this study, researchers looked at how a two-stage surgical procedure for removing soft tissue sarcomas (cancerous tumors) could help patients who have large areas of skin and tissue removed. They found that out of 73 patients, 21% had issues with their wounds after surgery, and 11% had their cancer come back, which shows that this surgical approach is effective and doesn’t worsen the chances of local recurrence. This matters because it gives patients a safe option for treatment while managing significant tissue loss. Who this helps: This helps patients undergoing surgery for soft tissue sarcomas.

PubMed

How to perform a root cause analysis for workup and future prevention of medical errors: a review.

2016

Patient safety in surgery

Charles R, Hood B, Derosier JM, Gosbee JW, Li Y +3 more

Plain English
This research paper focuses on how to effectively conduct a Root Cause Analysis (RCA) to prevent medical errors in healthcare, particularly in surgical settings. The review highlights the importance of a structured RCA process, which has been shown to reduce surgical errors when done properly. Implementing this approach can significantly improve patient safety and the quality of care provided. Who this helps: This helps patients and healthcare providers by reducing the risk of medical errors.

PubMed

CORR Insights®: how much tumor surgery do early-career orthopaedic oncologists perform?

2015

Clinical orthopaedics and related research

Biermann JS

PubMed

Sonography of cat scratch disease.

2015

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine

Melville DM, Jacobson JA, Downie B, Biermann JS, Kim SM +1 more

Plain English
This study looked at how ultrasound images can help identify cat scratch disease, which causes swelling in the area around the elbow, and how it differs from other conditions that cause similar symptoms. Researchers found that certain features on the ultrasound, like an uneven shape and a specific bright area (hyperechoic hilum), could significantly indicate cat scratch disease, with 5 out of 21 patients having this condition. Understanding these differences is important because it can help doctors make quicker and more accurate diagnoses for patients with these symptoms. Who this helps: This helps doctors and patients who might be dealing with cat scratch disease.

PubMed

The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework.

2015

Journal of multidisciplinary healthcare

Siegel GW, Biermann JS, Chugh R, Jacobson JA, Lucas D +5 more

Plain English
This study focused on how to effectively manage bone and soft tissue sarcomas, which are rare and complex cancers. It found that using a structured team approach, including a dedicated clinic and a tumor board, improves communication and coordination among healthcare providers, leading to better care for patients. This is important because it enhances the quality of treatment and helps more patients participate in clinical trials. Who this helps: This helps patients with bone and soft tissue sarcomas and the doctors who treat them.

PubMed

A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.

2015

European journal of cancer (Oxford, England : 1990)

Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS +9 more

Plain English
This study compared two different treatment options for patients with a type of cancer called high-risk soft tissue sarcoma. Researchers looked at how often patients needed to be hospitalized while receiving either the standard treatment (doxorubicin and ifosfamide) or an alternative (gemcitabine and docetaxel). They found that 35% of patients receiving the standard treatment were hospitalized, compared to 26% of those on the alternative treatment, which suggests that the alternative may be easier on patients, even though the difference was not very large. Who this helps: This benefits cancer patients and doctors by offering insights into potentially less harsh treatment options.

PubMed

Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.

2015

Journal of the National Comprehensive Cancer Network : JNCCN

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC +25 more

Plain English
This paper focuses on multiple myeloma (MM), a type of cancer that affects plasma cells in the bone marrow. It highlights that cases of MM are on the rise and provides updated guidelines for treating patients with both solitary plasmacytoma and newly diagnosed MM. These guidelines aim to improve patient care and outcomes in a growing number of cases. Who this helps: Patients with multiple myeloma and their healthcare providers.

PubMed

Nodular fasciitis: characteristic imaging features on sonography and magnetic resonance imaging.

2014

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine

Khuu A, Yablon CM, Jacobson JA, Inyang A, Lucas DR +1 more

Plain English
This study examined how nodular fasciitis appears on ultrasound and MRI to improve diagnosis. Researchers looked at six confirmed cases and found that the average size of the masses was 2.6 cm, often appearing oval with unclear edges, and typically located near fascia, which is connective tissue. Recognizing these imaging features is important because misdiagnosis can lead to unnecessary surgery. Who this helps: This benefits doctors and patients by helping ensure accurate diagnoses and treatments.

PubMed

Multiple myeloma, version 1.2013.

2013

Journal of the National Comprehensive Cancer Network : JNCCN

Anderson KC, Alsina M, Bensinger W, Biermann JS, Cohen AD +21 more

Plain English
This study looks at the latest guidelines for treating multiple myeloma, particularly when the disease comes back or worsens. It found that there are new treatment options available, known as salvage therapies, which can help manage the condition, and it suggests ways to reduce the side effects of these treatments. These updates are important because they can provide better care for patients who have limited options after their initial treatment fails. Who this helps: This helps patients with relapsed or progressive multiple myeloma.

PubMed

The musculoskeletal effects of cigarette smoking.

2013

The Journal of bone and joint surgery. American volume

Lee JJ, Patel R, Biermann JS, Dougherty PJ

Plain English
This study looked at how cigarette smoking affects bone health and recovery from injuries. It found that smoking lowers bone strength and raises the chances of fractures and injuries, with a particular increase in complications during and after surgery. Importantly, patients who quit smoking for a short time before surgery may lower these risks significantly. Who this helps: This benefits patients undergoing surgery, particularly those who smoke.

PubMed

Updates in the treatment of bone cancer.

2013

Journal of the National Comprehensive Cancer Network : JNCCN

Biermann JS

Plain English
This study focused on the treatment of primary bone cancers, which are rare but often curable. Researchers updated the treatment guidelines to include new information on specific types of bone tumors, like giant cell tumor of bone (GCTB) and chordoma. They highlighted how denosumab can be beneficial for treating GCTB and discussed the unique difficulties in treating the more aggressive chordoma. Who this helps: This helps patients with primary bone cancers and their doctors.

PubMed

Bone cancer.

2013

Journal of the National Comprehensive Cancer Network : JNCCN

Biermann JS, Adkins DR, Agulnik M, Benjamin RS, Brigman B +22 more

Plain English
The study focused on primary bone cancers, which are very rare and make up less than 0.2% of all cancers. It highlighted the need for specialized medical teams to effectively evaluate and treat these cancers, which include chordoma, giant cell tumor of the bone, and osteosarcoma. Proper follow-up care is essential to address any long-term effects of treatments like surgery and chemotherapy. Who this helps: This helps patients with bone cancer and their healthcare teams.

PubMed

CORR Insights®: incidence and risk factors for pulmonary embolism after primary musculoskeletal tumor surgery.

2013

Clinical orthopaedics and related research

Biermann JS

PubMed

Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology.

2013

The American journal of surgical pathology

Choi EY, Thomas DG, McHugh JB, Patel RM, Roulston D +4 more

Plain English
This study investigated a rare and aggressive type of soft tissue tumor called CIC-DUX4 sarcoma, found in four adults between the ages of 20 and 43. The researchers confirmed that all tumors had a specific genetic mutation (t(4;19)) linked to this cancer, and unfortunately, all patients died within about 17 months due to the disease's rapid progression. Understanding this tumor's unique features is crucial for improving diagnosis and treatment options. Who this helps: This helps patients with CIC-DUX4 sarcoma and their doctors.

PubMed

NCCN Task Force Report: Bone Health In Cancer Care.

2013

Journal of the National Comprehensive Cancer Network : JNCCN

Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF +6 more

Plain English
This research looked at how important it is to maintain bone health in people with cancer, as many face risks like brittle bones from treatments and fractures. The findings emphasized the need for effective screening and treatment to prevent complications, with the report underscoring that a team of healthcare professionals is crucial for managing these bone issues. Overall, better bone health in cancer patients can improve their quality of life and reduce painful complications. Who this helps: This helps cancer patients and their doctors.

PubMed

Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity.

2012

American journal of clinical oncology

Sabolch A, Feng M, Griffith K, Rzasa C, Gadzala L +5 more

Plain English
This study looked at factors that can lead to the return of soft tissue sarcomas in the arms or legs and how they might spread to other parts of the body. Out of 188 patients analyzed, 13% had their cancer return locally, and 24% experienced it spreading. Patients with higher-grade tumors or certain surgical conditions were more likely to face these issues, and those with local recurrences lived shorter lives; some had over a 16 times increased risk of poor survival. Who this helps: This research benefits patients with soft tissue sarcomas and their doctors by identifying those who may need more aggressive treatment.

PubMed

Dose--effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity.

2012

International journal of radiation oncology, biology, physics

Pak D, Vineberg KA, Griffith KA, Sabolch A, Chugh R +3 more

Plain English
This study looked at how radiation therapy affects the risk of femoral fractures in patients treated for soft tissue sarcomas in the upper leg. Among the 131 patients studied, only 4% suffered from fractures, with those who had femoral neck fractures receiving higher radiation doses—averaging 57.6 Gy—compared to non-fracture patients, who averaged only 22.9 Gy. Understanding these dose effects is important because it helps doctors improve treatment plans to lower the risk of fractures in patients undergoing similar therapies. Who this helps: This benefits patients with soft tissue sarcomas, as well as doctors developing treatment plans.

PubMed

The orthopedic gender gap: trends in authorship and editorial board representation over the past 4 decades.

2012

American journal of orthopedics (Belle Mead, N.J.)

Okike K, Liu B, Lin YB, Torpey JL, Kocher MS +3 more

Plain English
This study looked at how many women have been involved as authors and editorial board members in major orthopedic journals from 1970 to 2007. The research found that the percentage of female first authors rose from 0.8% to 6.5%, last authors from 0.0% to 4.3%, and editorial board members from 1.6% to 5.4%. While these numbers show improvement in women’s representation in orthopedics, the growth was slower compared to other medical fields, highlighting a persistent gender gap that needs to be addressed. Who this helps: This helps patients and promotes diversity within the medical community.

PubMed

Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.

2012

Journal of the National Comprehensive Cancer Network : JNCCN

Anderson KC, Alsina M, Bensinger W, Biermann JS, Cohen AD +23 more

Plain English
This paper discusses new guidelines for treating Waldenström's macroglobulinemia, a type of blood cancer. The updated treatment options now include newly developed drugs and clearer criteria for assessing how well these treatments work. It also provides guidance on managing nerve pain, which is a common issue for patients with this condition. Who this helps: These updates benefit patients with Waldenström's macroglobulinemia and their doctors.

PubMed

Role of radiotherapy in the management of desmoid tumors.

2011

International journal of radiation oncology, biology, physics

Gluck I, Griffith KA, Biermann JS, Feng FY, Lucas DR +1 more

Plain English
This study looked at how effective radiotherapy is for patients with desmoid tumors after surgery. Researchers reviewed the treatment outcomes of 95 patients and found that after three years, the chances of the tumors not coming back were similar regardless of whether patients had surgery, radiotherapy, or both, with rates of 84.6%, 92.3%, and 69.0% for each group respectively. Important factors linked to a higher risk of the tumors returning included having surgery at the head or neck and a history of prior surgery. Who this helps: This study benefits patients with desmoid tumors by providing insights into treatment effectiveness and recurrence risks.

PubMed

Accuracy of CT-guided percutaneous core needle biopsy for assessment of pediatric musculoskeletal lesions.

2011

Pediatric radiology

Hryhorczuk AL, Strouse PJ, Biermann JS

Plain English
This study looked at how well a specific type of biopsy, called CT-guided percutaneous core needle biopsy, can diagnose bone problems in children. Out of 63 biopsies performed on 61 kids, 84% were accurate in providing useful information about their conditions, with 78% being for benign issues and 22% for malignant ones. This is important because it shows that this biopsy method is reliable and safe for diagnosing bone lesions in children, potentially avoiding unnecessary surgeries. Who this helps: Patients, particularly children with musculoskeletal conditions, and their doctors.

PubMed

American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer.

2011

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Van Poznak CH, Temin S, Yee GC, Janjan NA, Barlow WE +8 more

Plain English
This study updated guidelines for using bone-modifying agents in patients with metastatic breast cancer that has spread to the bones. Researchers found that medications like denosumab, pamidronate, and zoledronic acid can help prevent serious bone-related problems, but there's no clear evidence that one works better than the others. The guidelines stress the importance of dental health before starting treatment and emphasize managing bone pain effectively when it begins. Who this helps: This helps patients with metastatic breast cancer and their doctors by providing clear treatment recommendations.

PubMed

Multiple myeloma.

2011

Journal of the National Comprehensive Cancer Network : JNCCN

Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A +20 more

PubMed

Metastatic bone disease: diagnosis, evaluation, and treatment.

2010

Instructional course lectures

Biermann JS, Holt GE, Lewis VO, Schwartz HS, Yaszemski MJ

Plain English
This study looked at how to better diagnose and treat cancer that has spread to the bones, known as bone metastases. Researchers found that using new treatments like bisphosphonates has improved the quality of life for cancer patients, and it's crucial to confirm the presence of metastasis to avoid wrong treatments. They emphasized that treatment plans should consider a patient’s expected lifespan and personal goals, and that less invasive options are available for those who may not be able to undergo surgery. Who this helps: This helps cancer patients, especially those with bone metastases.

PubMed

Bone cancer.

2010

Journal of the National Comprehensive Cancer Network : JNCCN

Biermann JS, Adkins DR, Benjamin RS, Brigman B, Chow W +19 more

PubMed

Metastatic bone disease: diagnosis, evaluation, and treatment.

2009

The Journal of bone and joint surgery. American volume

Biermann JS, Holt GE, Lewis VO, Schwartz HS, Yaszemski MJ

PubMed

Biopsy of soft tissue masses: evidence-based medicine for the musculoskeletal tumor society.

2009

Clinical orthopaedics and related research

Rougraff BT, Aboulafia A, Biermann JS, Healey J

Plain English
This study looked at how to perform biopsies on soft tissue masses, particularly which methods are most accurate and when a biopsy is necessary. They found that open biopsies provide the best diagnostic accuracy, outperforming core needle biopsies and fine needle aspirations. However, there wasn't enough information to determine which type of doctor should perform the biopsy for the best results, and more research is needed in this area. Who this helps: This is beneficial for doctors making decisions about biopsies for their patients with soft tissue masses.

PubMed

NCCN Task Force Report: Bone Health in Cancer Care.

2009

Journal of the National Comprehensive Cancer Network : JNCCN

Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF +6 more

Plain English
This report looks at the importance of keeping bones healthy for cancer patients at different stages of their treatment. It found that certain cancer treatments, like chemotherapy and hormone therapy, increase the risk of osteoporosis, which can lead to serious bone problems. The National Comprehensive Cancer Network brought together experts to discuss better ways to screen for bone loss and manage issues related to bones affected by cancer. Who this helps: This helps cancer patients and their doctors.

PubMed

NCCN clinical practice guidelines in oncology: multiple myeloma.

2009

Journal of the National Comprehensive Cancer Network : JNCCN

Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A +19 more

PubMed

CT-guided biopsy of bone: a radiologist's perspective.

2008

AJR. American journal of roentgenology

Espinosa LA, Jamadar DA, Jacobson JA, DeMaeseneer MO, Ebrahim FS +4 more

Plain English
This paper looks at how to safely perform a needle biopsy of bones to prevent cancer cells from spreading to nearby tissues. The authors provide guidelines and examples that show how different techniques can reduce risks during the procedure. Their findings are crucial for improving the safety and effectiveness of bone biopsies, which can help doctors get accurate samples without harming surrounding areas. Who this helps: This helps patients undergoing bone biopsies and the doctors performing the procedures.

PubMed

Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.

2008

The oncologist

Lucas DR, Kshirsagar MP, Biermann JS, Hamre MR, Thomas DG +2 more

Plain English
This study looked at how high-grade soft tissue sarcomas in 31 patients responded to neoadjuvant chemotherapy before surgery. Researchers found that 71% of patients had a poor histologic response to the treatment but surprisingly, 13 out of those 22 patients with a poor response were still cured. This matters because it shows that the way tumors respond to chemotherapy on a microscopic level may not accurately predict patient survival, suggesting that doctors should consider a broader range of factors when determining treatment outcomes. Who this helps: This helps patients with soft tissue sarcomas and their doctors by providing better insights into treatment effectiveness.

PubMed

Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors.

2008

The oncologist

Tawbi H, Thomas D, Lucas DR, Biermann JS, Schuetze SM +3 more

Plain English
This study looked at two rare types of tumors found in young people, synovial sarcomas (SnSrcs) and malignant peripheral nerve sheath tumors (MPNSTs), specifically focusing on a protein called epidermal growth factor receptor (EGFR). The researchers found that 71% of SnSrcs and 62.5% of MPNSTs expressed EGFR, but there were no mutations that typically activate this protein. This is important because it means that using certain targeted therapies for these tumors might not be effective, highlighting the need for further clinical trials, like the one using a drug called cetuximab, to see if blocking EGFR could be beneficial. Who this helps: Patients with synovial sarcomas and malignant peripheral nerve sheath tumors.

PubMed

Multiple myeloma. Clinical practice guidelines in oncology.

2007

Journal of the National Comprehensive Cancer Network : JNCCN

Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A +16 more

PubMed

Web-based resources for orthopaedic oncology information.

2007

Clinical orthopaedics and related research

Biermann JS, Aboulafia AJ

Plain English
This study looked at online resources for information about bone cancer and related treatments. Researchers found 79 websites, but only 5 were suitable for patients and 7 for healthcare providers, with just one of each being peer-reviewed. This is important because it highlights a lack of reliable online information for bone cancer patients compared to other cancers, making it harder for them to find trustworthy guidance. Who this helps: Patients with bone cancer and their doctors.

PubMed

Bone cancer.

2007

Journal of the National Comprehensive Cancer Network : JNCCN

Biermann JS, Adkins D, Benjamin R, Brigman B, Chow W +19 more

PubMed

Orthopaedic information: how to find it fast on the Internet.

2007

Instructional course lectures

Biermann JS, Golladay GJ, Clough JF, Schelkun SR, Alexander AH

Plain English
This research looked at how orthopaedic surgeons can quickly find reliable information online. The study found that there are many effective strategies and resources available, making it easier for surgeons to keep up with the latest research and provide better education for their patients. This is important because it helps ensure that both doctors and patients have access to the most current and accurate information about orthopaedic care. Who this helps: This helps orthopaedic surgeons and their patients.

PubMed

Chordoma: the nonsarcoma primary bone tumor.

2007

The oncologist

Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM +1 more

Plain English
This study looked at chordomas, which are rare tumors that grow on bones, mainly around the base of the skull and the lower spine. It was found that about 50% of these tumors occur in the lower spine, and although aggressive treatment can improve outcomes, patients who face a recurrence usually have a poor prognosis. For those who do relapse, therapies like surgery and radiation can help stabilize their condition, with some patients benefitting from treatments that have shown to control the tumor in 33% of cases after two years. Who this helps: This information benefits patients with chordomas and their doctors by providing insights into treatment options.

PubMed

Frequent Co-Authors

Melissa Alsina Carol Ann Huff Seema Singhal Keith Stockerl-Goldstein Joachim Yahalom Rashmi Chugh Noopur Raje George Somlo Adetola Kassim

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.